Bull Rankings model

Nasdaq, Inc. (NDAQ) stock analysis

Financial Data & Stock Exchanges. Scored on the same transparent model behind the daily rankings.

★
NDAQ
Nasdaq, Inc. · Financial Data & Stock Exchanges
51.2Financial strength
$93.65Oct 9 close$52.3B
1Y Target$108.69Analyst consensus · 16 analysts
5Y Target$159.13Compound horizon
10Y Target$236.06Long-dated conviction
FCF$2.0bTTM · 06/26
C+
FCF $2.0b — respectable but not differentiating · Trailing twelve months to 06/26 (operating cash flow − capex).
Rev+11.6%FY YoY
B
Revenue +11.6% — at or above S&P median · Computed from the last two annual revenue figures (FY YoY).
D/E0.78
B
D/E 0.78 — near the Financial Services debt median (≈60th pctile)
P/E27.3x
C
P/E 27.3 — expensive vs Financial Services peers (≈90th pctile)
PEG1.47
B
PEG 1.47 — acceptable premium for growth

Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology

Financial strength · 51.2 / 100
Profitability79.6
Value (P/B)13.2
Income45.8

A peer-relative read for financials on profitability (ROE), valuation, and covered income — the quality-growth (FCF/ROIC) screen doesn't apply to balance-sheet businesses. Not comparable to the 0–100 quality-growth score shown on other stocks.

Entry · Margin of safety
52-week rangeNear 52-week high
8% off the 12-month high

Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards

Why now
Financial Data & Stock Exchanges · market cap $52.3b. 8% off the 52-week high of $101.79. Revenue growing +12%, comfortably above the S&P median. 16 sell-side analysts rate this a Buy with a mean 1-yr target of $108.69 (implying +16% upside).
Moat
Net margin 35% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 17% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 99% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Horizon
1-3 yr $108.69 (16-analyst consensus) — fundamentals + valuation re-rating. 5 yr $159.13 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $236.06 if current growth sustains into durable earnings power.

Not enough history yet — the model records NDAQ's score after each daily run, and the chart appears once a few days have accumulated.

NDAQ at a glance

FINANCIAL STRENGTH · BANKPROFITABILITY80VALUE13COVERED INCOME4651.2/100 on our peer scale — not the quality-growth score.
PRICE IN ITS 52-WEEK RANGE$93.7LOW $76.6HIGH $102Trading at the 68th percentile of its 52-week range ($76.6–$102).
ONE-YEAR MOVE VS ITS BETAFLATThis stock+4%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.

Same audited fundamentals as the score, unless a card says otherwise.

Analyst estimate revisions

30-day change-0.1%
90-day change+3.9%
Forward EPS estimate$4.67

Over the last 90 days, what analysts expect NDAQ to earn is drifting higher (+3.9%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →

Shares to buy
21
Position size
$1,967
3.9% of portfolio
Stop price
$70.24
25% below $93.65
$ at risk if stopped
$491.66
budget $500.00 · 1% of portfolio

Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.

Nasdaq, Inc. (NDAQ): score, valuation & FAQ

Nasdaq, Inc. (NDAQ) is a Financial Data & Stock Exchanges company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.

NDAQ is graded on the same transparent quality-growth model — quality, growth and value — behind the daily Bull Rankings.

Is NDAQ a good stock to buy?

Bull Rankings grades NDAQ on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. A score is a quantitative screen of Nasdaq, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

How does Bull Rankings grade NDAQ?

As a bank, insurer or REIT, NDAQ isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage.

Is NDAQ overvalued or undervalued?

We don't publish a discounted-cash-flow value for NDAQ, and not because the business is unprofitable. For a lender, insurer or property trust, "free cash flow" measures balance-sheet growth rather than owner earnings — loan originations and repayments run through operating cash flow — so discounting it would produce a confident-looking number with nothing behind it. NDAQ is judged on book value, return on equity and income cover instead, which is what the financial-strength card shows.

What are the main risks of investing in NDAQ?

Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.

New to these metrics? See the guides and the methodology.

More Exchanges & Financial Data stocks by score

All Financial Services rankings →

Analyze another ticker →